LL-37: Research Profile, Dosages & Supplier Prices
LL-37 is a immune research compound with a molecular weight of 4493.3 g/mol and a research half-life of short (rapid proteolytic turnover). LL-37 is the only human member of the cathelicidin family of antimicrobial peptides - a 37-amino-acid alpha-helical peptide cleaved from the hCAP-18 precursor protein. It is produced by neutrophils, epithelial cells and keratinocytes and serves as a first-line innate immune effector with direct broad-spectrum antimicrobial activity against bacteria, fungi and enveloped viruses.
Research Use Only (RUO). Not for human or veterinary use. Not medical advice.
| Sequence | Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser |
| Formula | C205H340N60O53 |
| Mol. weight | 4493.3 g/mol |
| Half-life | Short (rapid proteolytic turnover) |
| Forms sold | Lyophilized powder |
What is LL-37?
Beyond direct pathogen killing, LL-37 is heavily studied as an immune modulator: it chemoattracts immune cells, neutralizes bacterial endotoxin (LPS), modulates TLR signaling, and influences wound healing and angiogenesis. Research spans infection models, biofilm disruption, inflammatory bowel disease, psoriasis (where LL-37 is implicated as an autoantigen), and even cancer biology. Its dual pro- and anti-inflammatory behavior makes it one of the more context-dependent peptides in the research catalog.
Mechanism of Action (Research Context)
Amphipathic alpha-helix inserts into and disrupts microbial membranes (carpet/toroidal-pore models). Binds and neutralizes LPS. Immunomodulatory actions via FPRL-1/FPR2, P2X7 and EGFR transactivation; chemotactic for neutrophils, monocytes and T cells.
Research Areas
LL-37 Dosages in Research
Cell-culture antimicrobial assays typically use low micromolar concentrations; animal infection models use microgram-per-kilogram dosing. Research-context only.
Dosage information is a summary of published laboratory research and is provided for informational purposes only. These compounds are not for human use.
Storage & Handling
Lyophilized: -20C desiccated. Reconstituted: 2-8C, use within 1-2 weeks. LL-37 aggregates readily in solution - prepare fresh dilutions and avoid repeated freeze-thaw.
LL-37 Supplier Price Comparison
No tracked suppliers stock LL-37 yet — inventory syncs run continuously. Check our supplier reviews.